Inside informationEnglish
Press Release: Sanofi and Regeneron’s Dupixent approved in the US as the first and only medicine for allergic fungal rhinosinusitis
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Sanofi
- Filed
- 24/02/2026, 15:30
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 116459_20260224